Clinical Trial Update: BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial BEBOP evaluating belumosudil for prevention and treatment of bronchiolitis obliterans syndrome and bronchiolitis obliterans is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Bronchiolitis Obliterans Syndrome
• Graft-versus-host Disease
• Lung Diseases

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans | Phase 2 | Status: RECRUITING